- Report
- November 2025
- 150 Pages
Global
From €5374EUR$5,950USD£4,604GBP
- Report
- February 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- September 2026
- 487 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- September 2026
- 563 Pages
Global
From €5283EUR$5,850USD£4,527GBP
- Report
- November 2025
- 185 Pages
Global
From €4064EUR$4,500USD£3,482GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2519EUR$2,789USD£2,158GBP
- Report
- September 2026
- 183 Pages
Global
From €3202EUR$3,545USD£2,743GBP
€3557EUR$3,939USD£3,048GBP
- Report
- February 2026
- 250 Pages
Global
From €4055EUR$4,490USD£3,474GBP
- Report
- May 2026
- 150 Pages
Global
From €2438EUR$2,699USD£2,089GBP
- Report
- June 2026
- 150 Pages
Global
From €4290EUR$4,750USD£3,676GBP
- Report
- August 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- April 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- April 2026
- 160 Pages
Global
From €2998EUR$3,320USD£2,569GBP
€3748EUR$4,150USD£3,211GBP
- Report
- March 2026
- 135 Pages
Global
From €4380EUR$4,850USD£3,753GBP
- Report
- November 2025
- 150 Pages
United States
From €3567EUR$3,950USD£3,057GBP
- Report
- July 2025
- 120 Pages
Global
From €5374EUR$5,950USD£4,604GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1355EUR$1,500USD£1,161GBP
- Report
- June 2024
- 200 Pages
Global
From €7180EUR$7,950USD£6,152GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1806EUR$2,000USD£1,548GBP
- Report
- June 2024
- 200 Pages
Global
From €7180EUR$7,950USD£6,152GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more